Elastase, myeloperoxidase, nitric oxide metabolites and oxidative status in subjects with clinical stable chronic renal failure on conservative treatment

Clinical Hemorheology and Microcirculation

Volumn 43, Issue 3, 2009, Pages 253-258

  Caimi, Gregorio ^a   Carollo, Caterina ^a   Montana, Maria ^a   Vaccaro, Francesco ^a   Presti, Rosalia Lo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Chronic renal failure; Elastase; Myeloperoxidase; Nitric oxide; Oxidative status

Indexed keywords

ALPHA 1 ANTITRYPSIN; CREATININE; ELASTASE; HEMOGLOBIN; MYELOPEROXIDASE; NITRIC OXIDE; POLYUNSATURATED FATTY ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CREATININE CLEARANCE; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LEUKOCYTE FUNCTION; LIPID PEROXIDATION; MALE;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LEUKOCYTES; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; PANCREATIC ELASTASE; PEROXIDASE; SPECTROPHOTOMETRY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 70350437770     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2009-1237     Document Type: Article

References (32)

1. M. Annuk, I. Soveri, M. Zilmer, L. Lind, J. Hulthe and B. Fellström, Endothelial function, CRP and oxidative stress in chronic kidney disease, Journal of Nephrology 18 (2005), 721-726.
2. A. Atamer, Y. Kocyigit, S.A. Ecder, S. Selek, N. Ilhan, T. Ecder and Y. Atamer, Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease, Journal of Nephrology 21 (2008), 924-930.
3. R.H. Boger and C. Zoccali, ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease, Atherosclerosis 4(Suppl.) (2003), 23-28.
4. G. Caimi, B. Canino, F. Vaccaro, M. Montana, C. Carollo, G. Oddo and R. Lo Presti, Polymorphonuclear leukocyte rheology and cytosolic Ca2+ content after activation in chronic renal failure, Nephrology 6 (2001), 113-117.
5. G. Caimi, M. Montana, C. Carollo, F. Porretto, F. Vaccaro, B. Canino and R. Lo Presti, Polymorphonuclear leukocyte integrins in chronic renal failure, Clinical Hemorheology and Microcirculation 32 (2005), 43-49. (Pubitemid 40164159)
6. S. Chevion, D.S. Moran, Y. Heled, Y. Shani, G. Regev, B. Abbou, E. Berenshtein, E.R. Stadtman and Y. Epstein, Plasma antioxidant status and cell injury after severe physical exercise, Proceedings of the National Academy of Sciences of the United States of America 100 (2003), 5119-5123.
7. C. Di Massimo, P. Scarpelli, N. Di Lorenzo, G. Caimi, F. Di Orio and M.G. Tozzi-Ciancarelli, Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age, Life Sciences 78 (2006), 1163-1167. (Pubitemid 43176709)
8. C.M. Dollery, C.A. Owen, G.K. Sukhova, A. Krettek, S.D. Shapiro and P. Libby, Neutrophil elastase in human atherosclerotic plaques, Circulation 107 (2003), 2829-2836.
9. U. Forstermann, H. Kleinert, I. Gash, P. Schwarz, E.I. Closs and N.J. Dun, Expression and expressional control of nitric oxide synthases in various cell types, Advances in Pharmacology 34 (1995), 171-186.
10. J. Galle, S. Seibold and C. Wanner, Inflammation in uraemic patients: what is the link?, Kidney Blood Pressure Research 26 (2003), 65-75. (Pubitemid 36677061)
11. M. Haag-Weber andW.H. Horl, Uremia and infections: mechanisms of impaired cellular host defense, Nephron 63 (1993), 125-131.
12. M. Haag-Weber and W.H. Horl, Dysfunction of polymorphonuclear leucocytes in uremia, Seminars in Nephrology 16 (1996), 192-201.
13. T. Hayama, M. Matsuyama, K. Funao, T. Tanaka, K. Tsuchida, Y. Takemoto, Y. Kawahito, H. Sano and T. Nakatani, Benefical effect of neutrophil elastase inhibitor on renal warm ischemia-reperfusion injury in the rat, Transplantation Proceedings 38 (2006), 2201-2202.
14. L.L. Ji, Antioxidants and oxidative stress in exercise, Proceedings of the Society for Experimental Biology and Medicine 222 (1999), 283-292.
15. K. Kalantar-Zadeh and V.S. Balakrishnan, The Kidney Disease Wasting: inflammation, oxidative stress and diet-gene interaction, Hemodialysis International 10 (2006), 315-325.
16. I. Karamouzis, P.A. Sarafidis, M. Karamouzis, S. Iliadis, A.B. Haidich, A. Sioulis, A. Triantos, N. Vavatsi-Christaki and D.M. Grecas, Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease, American Journal of Nephrology 28 (2007), 397-404.
17. S. Kopprash, J. Graessler, R. Seibit, H.J. Naumann, K. Scheuch, R. Henbge and U. Schwanebek, Leukocyte responsiveness to substances that activate the respiratory burst is not altered in borderline and essential hypertension, Journal of Human Hypertension 10 (1996), 69-76.
18. Z.Q. Liu, S.M.Wildhirt and H.H. Zhou, Specificity of inducible nitric-oxide synthase inhibitors: prospects for their clinical therapy, Acta Pharmacologica Sinica 20 (1999), 1052-1056.
19. R. Lo Presti, B. Canino, F. Vaccaro, M. Montana, G. Ventimiglia, G. Grifò and G. Caimi, Chronic renal failure: leukocyte rheology and polymorphonuclear cytosolic Ca2+ concentration, Current Medical Research Opinion 15 (1999), 202-207.
20. C.M. Loughrey, I.S. Young, J.H. Lightbody, D.McMaster, P.T. McNamee and E.R. Trimble, Oxidative stress in haemodialysis, The Quarterly Journal of Medicine 87 (1994), 679-683.
21. I.M.J. Mackenzie, A. Ekangaki, J.D. Young and C.S. Garrard, Effect of renal function on serum nitrogen oxide concentrations, Clinical Chemistry 42 (1996), 440-444.
22. Y. Maruyama, B. Lindholm and P. Stenvinkel, Inflammation and oxidative stress in ESRD - the role of myeloperoxidase, Journal of Nephrology 17 (2004), 72-76.
23. N.J. Miller, C. Rice-Evans, M.J. Davies, V. Gopinathan and A.Milner, A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates, Clinical Science 84 (1993), 407-412.
24. S. Moncada, R.M.J. Palmer and E.A. Higgs, Nitric oxide: physiology, pathophysiology and pharmacology, Pharmacological Reviews 43 (1991), 109-142.
25. C. Nathan, Inducible nitric oxide synthases: what difference does it make?, Journal of Clinical Investigations 100 (1997), 2417-2423.
26. D.N. Reddan, P.S. Klassen, L.A. Szczech, J.A. Coladonato, S. O'Shea, W.F. Owen Jr. and E.G. Lowrie, White blood cells as a novel mortality predictor in haemodialysis patients, Nephrology Dialysis Transplantation 18 (2003), 1167-1173.
27. J.S. Sandhu, A.P.S. Narang, K.L. Bhatia, J. Adlakha and D. Khullar, Trace elements and oxidative stress in chronic renal failure, Trace Elements and Electrolytes 22 (2005), 233-235.
28. P. Stenvinkel, Inflammation in end-stage renal disease: The hidden enemy, Nephrology 11 (2006), 36-41.
29. P. Vallance, A. Leone, A. Calver, J. Collier and S. Moncada, Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure, Lancet 339 (1992), 572-575.
30. J.B. Weinberg, Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes - a review, Molecular Medicine 4 (1998), 557-591.
31. J.W. Yoon, M.V. Pahl and N.D. Vaziri, Spontaneous leukocyte activation and oxigen-free radical generation in end-stage renal disease, Kidney International 71 (2007), 167-172.
32. B.A. Zachara, J. Gromadzinska, W. Wasowic and Z. Zbrog, Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review, Acta Biochimica Polonica 53 (2006), 663-677.